Ubiquitin-conjugating E2 enzyme variant 1 (Ube2v1), one member of ubiquitin-conjugating E2 enzyme variant proteins, has been controversially suggested as both a candidate oncogene or a tumor suppressor [19, 21–23]. This evidence concerns the gene UBE2V1 and neoplasm.